Table 2.
Comparison of 3 and 6-Month Postsurgery Sensation Status of ENSMSLS Patients With That of NSM Patients
| Parameter | NSM (n = 30) | ENSMSLS (n = 30) | OR* | 95% CI of OR | P |
|---|---|---|---|---|---|
| Pressure sensation decrease | 28/30 | 12/30 | 21.00 | 4.20, 105.04 | <.0001 |
| (3 months) | |||||
| Pressure sensation decrease | 11/30 | 24.18 | 4.82, 121.61 | <.0001 | |
| (6 months) | |||||
| Temperature sensation decrease | 30/30 | 25/30 | 13.16‡ | 0.69, 249.48‡ | .02 |
| (3 months)† | |||||
| Temperature sensation decrease | 23/30 | 19.47‡ | 1.06, 358.38‡ | .005 | |
| (6 months)† | |||||
| Vibration sensation loss | 10/30 | 0/30 | 31.24‡ | 1.73, 563.16‡ | .0006 |
| (3 month)§ | |||||
| Vibration sensation loss | 0/30 | 31.24‡ | 1.73, 563.16‡ | .0006 | |
| (6 month)§ | |||||
| Nipple transposition | 16/30 | 12/30 | 1.71 | 0.62, 4.77 | .30 |
Sensation status in the matched NSM group was conducted only once, on the day when they were called back for re-examination.
Odds ratio of patients in the NSM surgical group compared with patients in the ENSMSLS group.
Because all the patients in the NSM group had a drop in sensitivity to temperature, the OR cannot be calculated normally. The risk decrease for the ENSMSLS group vs the NSM group was 16.67% in 3 months and 23.33% in 6 months.
All logit estimators with this marker use a correction of 0.5 in every cell of those tables that contain a zero.
For vibration sensation change; because no patients in the ENSMSLS group had lost their vibration sensation, the OR cannot be calculated normally. There was a 33.33% risk decrease for ENSMSLS group compare to NSM group at both the 3 and 6 month follow-ups.